3rd Quarter - Report
THE DUBERSTEIN GROUP INC. for PHRMA INC.
Client
Income
$100,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Tax reform, including monitoring offsets for medical device tax repeal - HR 436, Health Care Cost Reduction Act of 2012.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL P MEYER | — |
Budget/Appropriations BUD
Fiscal cliff issues: prospects for tax reform, sequestration, and impact of budget negotiations on Medicare and healthcare issues - Congressional action on these issues; proposed legislation on these issues; Executive Branch action on these issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN CHAMPLIN | — |
| DANIEL P MEYER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.